Early Outcomes After Initiation of Faricimab for Neovascular Age-Related Macular Degeneration
Among patients with nAMD receiving faricimab, visual acuity improved in treatment-naïve eyes, and both previously treated and treatment-naïve eyes experienced anatomical improvement.
Authors
- Rachel A. Myers (ORCID: https://orcid.org/0000-0003-0086-8339)
- Ayesha Ahmed
- Theodore Leng (ORCID: https://orcid.org/0000-0002-8461-3562)
- David Tabano (ORCID: https://orcid.org/0000-0001-7657-0809)
- Vincent Garmo (ORCID: https://orcid.org/0000-0003-3073-0373)
- Giulio Barteselli (ORCID: https://orcid.org/0000-0003-0533-1135)
- Rishi P. Singh (ORCID: https://orcid.org/0000-0001-5859-8162)
- Jacqueline K. Shaia (ORCID: https://orcid.org/0000-0001-7873-669X)
- Ferhina S. Ali
- Durga S. Borkar
Institutions
- Cleveland Clinic (US)
- Duke University (US)
- New York Medical College (US)
- San Francisco Department of Public Health (US)
- Federal Reserve Bank of Cleveland (US)
- Cleveland Eye Clinic (US)
- Martin Health System (US)
- Case Western Reserve University (US)
- Stanford University (US)
Publication Details
- Journal
- Ophthalmic surgery, lasers & imaging retina
- Published
- 2025-05-15
- DOI
- https://doi.org/10.3928/23258160-20250304-02
- Citations
- 3
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.12